OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
15
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
Q Exactive
(1)
Publication Date
2016
(1)
Release Date
2025
(3)
2023
(3)
2021
(3)
2022
(2)
2024
(1)
2020
(1)
2014
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.
Not available
S-EPMC4230643
|
biostudies-literature
Cite
Adjuvant Secretomes
Adjuvant-induced human monocyte secretome profiles reveal adjuvant- and age-specific protein signatures.
ORGANISM(S):
Homo Sapiens (ncbitaxon:9606)
2016-07-20
|
MSV000079960
|
MassIVE
Cite
Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic Stroke: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials.
Not available
S-EPMC8094030
|
biostudies-literature
Cite
Worldwide Organization of Neurocritical Care: Results from the PRINCE Study Part 1.
Not available
S-EPMC7223982
|
biostudies-literature
Cite
Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
Not available
S-EPMC11743801
|
biostudies-literature
Cite
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
Not available
S-EPMC7615263
|
biostudies-literature
Cite
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study.
Not available
S-EPMC10859139
|
biostudies-literature
Cite
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8491132
|
biostudies-literature
Cite
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets